|
What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council
How common are aneurysms? It is estimated that 1.5-5 percent of the general population has or will develop a cerebral aneurysm. It is also estimated that 3-5 million people in the United States have cerebral aneurysms, but most are not producing any symptoms. Annually, between 0.5-3 percent of people with a brain aneurysm may suffer from bleeding. How do aneurysms form? Are people born with an aneurysm?
Are all aneurysms the same? Brain aneurysms are all different. They vary in size, shape and location. Size
Shape Aneurysms can be:
What causes an aneurysm to bleed?
What are the chances that an unruptured aneurysm may bleed? Many factors determine whether an aneurysm is likely to bleed. These include the size, shape and location of the aneurysm and symptoms that it causes. Smaller aneurysms that are uniform in size may be less likely to bleed than larger, irregularly shaped aneurysms. Once an aneurysm has bled, there is a very high chance of re-bleeding. That is why treatment as soon as possible is recommended. What happens if an aneurysm bleeds? If an aneurysm ruptures, it leaks blood into the space around the brain. This is called a "subarachnoid hemorrhage". Depending upon the amount of blood, it can produce:
The hemorrhage may also damage the brain directly, usually from bleeding into the brain itself. This is called a "hemorrhagic stroke" This can lead to
What is the usual damage to the brain after an aneurysm bleeds? Once an aneurysm bleeds, there is a 30-40 percent chance of death, and a 20-35 percent chance of moderate to severe brain damage, even if the aneurysm is treated. 15-30 percent of patients have only mild difficulties or almost none. If the aneurysm is not treated quickly enough, another bleed may occur from the already ruptured aneurysm. In 15-20 percent of patients, vasospasm (irritation by the leaked blood causing narrowing of the blood vessels) may occur. This can lead to further brain damage. Other problems may include hydrocephalus (enlargement of the spaces within the brain that produce cerebrospinal fluid); difficulty breathing that requires a mechanical ventilator, and infection. Heart and lung problems may result due to extensive brain damage that can affect the body's normal functions. Why is the damage so extensive after bleeding? Once blood enters the brain and the space around it, direct damage to the brain tissue and brain function results. This amount of damage is usually related to the amount of blood. Damage is due to the increased pressure and swelling from bleeding directly into the brain tissue, or from local cellular damage to brain tissue from irritation of blood in the space between the brain and the skull. Blood can also irritate and damage the normal blood vessels and cause vasospasm (constriction). This can interrupt normal blood flow to the healthy brain tissue and can cause even more brain damage. Will treating a ruptured aneurysm reverse or improve brain damage? Once an aneurysm bleeds and brain damage occurs, treating the aneurysm will not reverse the damage. Treatment is necessary, but the treatment only helps prevent more bleeding, which can cause more damage to the brain and, consequently, to the body's functions. If bleeding has already caused brain damage, patients may benefit from rehabilitation therapy once the aneurysm has been treated. How is a treatment method for aneurysm chosen? Each patient and each aneurysm is different. Doctors must evaluate the risk factors that favor treatment vs. non-treatment and must decide which technique may be best. It is important to consult with experts in this field. This should include a discussion with a cerebrovascular neurosurgeon who specializes in surgically clipping aneurysms and an interventional neuroradiologist/endovascular surgeon who specializes in the less invasive treatment of cerebral aneurysms by coiling. These 2 types of medical specialists are usually different, and have different expertise and training backgrounds. It is highly recommended to have a consultation with both types of physicians. How should an aneurysm be treated? The best treatment depends upon many things, including whether the aneurysm has ruptured or not. A ruptured aneurysm usually requires treatment right away, because the re-bleeding rate remains quite high. However, the treatment time and options for treatment depend upon the size, location and shape of the aneurysm, as well as the patient's overall medical condition. If an aneurysm has not ruptured, the treatment decision depends upon its size, location and shape, and the patient's symptoms. Each factor is important and requires consultation with a neurosurgeon and an interventional neuroradiologist who has special skills and training in treating these types of aneurysms. What treatments are available?
For a complicated surgery or endovascular treatment, or if an aneurysm has bled into the brain, hospitalization may be for 1-4 weeks , depending upon the patient's medical condition and any complications caused by the hemorrhage.
All these risks need to be carefully considered when deciding upon a course of treatment. There are risks if the aneurysm is not treated. The aneurysm may bleed or grow in size. What follow-up is required after aneurysm treatment? There are two follow-up procedures depending on the type of treatment:
About Strokes and Cerebrovascular Diseases Stroke and cerebrovascular diseases are the third-leading cause of death and a leading cause of major disability in the United States. More than 700,000 new and recurrent strokes occur each year, resulting in about 167,000 deaths and more than 250,000 permanent disabilities per year in the United States. More than 4.7 million stroke survivors are alive today. Hemorrhagic strokes are caused by bleeding into the brain, causing either death or major disability. Cerebral aneurysm ruptures account for the majority of these hemorrhagic strokes each year. About ISAT What is ISAT? Which kind of patients suffering from an aneurysm were treated in ISAT? ISAT's primary criteria for enrollment was that a patient with a ruptured aneurysm who was treated at one of the trial centers had to be judged equally suitable for either surgical or endovascular therapy by the treating physician. The trial was designed to show whether a policy of endovascular treatment would reduce the percentage of patients with poor or moderate outcomes at one year post treatment compared to a policy of surgical treatment. The trial protocol was peer reviewed and approved by the Medical Research Council of the United Kingdom. How many patients were enrolled in ISAT and what does the data mean? On May 2, 2002, after enrolling 2143 of the planned 2,500 patients, ISAT halted patient enrollment into the trial following a planned data review by the Data Monitoring Committee that found that the trial had reached its primary endpoint and that it was no longer ethical to randomize patients to neurosurgery with clipping. Although enrollment ended, data analysis and patient follow-up still continues. How can I find more date about ISAT? On October 26, 2002, The Lancet (www.thelancet.com) published the ISAT findings. The article was reprinted in the November-December issue of the Journal of Stroke and Cerebrovascular Disease. For the 1594 patients with one-year post treatment outcomes, the relative risk of dependence or death for patients assigned to endovascular therapy was 22.6% lower than that of patients assigned to surgical therapy with an absolute risk reduction of 6.9%. The study concluded that "in patients with a ruptured intracranial aneurysm, for which endovascular coiling and neurosurgical clipping are therapeutic options, the outcomes in terms of survival free of disability at 1 year is significantly better with endovascular coiling." The risk of rebleeding after one year was low for both procedures- two per 1276 patient years for endovascular therapy and zero per 1081 patient years for surgery. Will there be additional data coming out of this trial? Begun in 1994 with a pilot study and commencing full enrollment in 1997, ISAT involved 43 centers in the UK, Europe, Australia, and North America. The trial was funded by the Medical Research Council (UK), French Ministry of Health, Assistance Publique, Hopitaux de Paris, Canadian Institutes of Health Research, and the Stroke Association of the UK. ISAT will continue to publish data and findings through 2007. Among the issues that ISAT will address are long-term risk of rebleeding, neuropsychological outcomes, quality of life and health economic results. What people are saying about ISAT? "Patients with an aneurysm really need to be evaluated in a center that offers both kinds of treatment, in a truly unbiased setting where their aneurysm is evaluated by experts." For more information, contact the American Stroke Association, a division of the American Heart Association, at 1-888-4-STROKE (1-888-478-7653) or visit StrokeAssociation.org.
|